Exits
China AI player Mobvoi files for Hong Kong IPO
Mobvoi, which claims to be China’s largest revenue-generating artificial intelligence (AI) company focusing on content generation, has filed for a Hong Kong IPO.
Japan buyouts: Bucking the trend
Japan remains a private equity hotspot despite muted buyout activity elsewhere in Asia. Take-private and sponsor-to-sponsor opportunities make for a more textured local market
Deal focus: Goldman secures $1bn exit from India’s ReNew
Goldman Sachs has clocked a healthy return from ReNew Energy Global after helping the company diversify its offering and navigate the regulatory pitfalls of India’s renewables space
Asia GPs must get smarter on target selection, costs - Bain & Co
Careful target selection – based on geography and sector – and increased emphasis on cost controls during ownership will be critical factors for Asian private equity investors as the industry braces for a downturn, according to Bain & Company.
China rolls out guidelines for offshore IPOs
China has sought to facilitate overseas IPOs by local companies through the introduction of a new regulatory regime to guide the process.
4Q analysis: Who wants China?
Pan-regional GPs get traction by highlighting their Asia ex-China credentials; buyouts rebound as growth capital – and China – continue to recede; India impresses with bumper exit proceeds
GPs seek alternatives in absence of US IPOs – AVCJ Forum
Private markets investors have responded to the drop-off in US IPO activity by exploring listings within Asia, while M&A is expected to play a more important role, the AVCJ Private Equity & Venture Forum heard.
PE-backed Mankind Pharma files for India IPO
Indian drug maker Mankind Pharma has filed for a domestic IPO, setting up an exit for Capital International, a private equity arm of Capital Group.
AVCJ Awards 2022 - nominations have closed
Nominations for the 2022 AVCJ Private Equity & Venture Capital Awards have now closed. Many thanks to all those who participated.
Navis exits medical cold chain player to US strategic
Navis Capital Partners has sold 100% of B Medical Systems, a Luxembourg-based biotech cold chain provider with significant Asian operations, at an enterprise value of EUR 460m (USD 469m).
Potentia agrees $623m exit from Australia's Micromine
Australia’s Potentia Capital has agreed to exit its position in local mining software provider Micromine to UK-based industrial software player AspenTech in a deal worth AUD 900m (USD 623m).
ESG in M&A: Eloquent exits
Private equity firms are increasingly presenting portfolio companies’ sustainability credentials in a prepared and formal way in trade sale situations. It appears to be worth the trouble
Quadrant exits Australia underwear brand to Swedish strategic
Quadrant Private Equity has exited Australian hygiene apparel brand Modibodi to Swedish strategic Essity for AUD 140m (USD 96m).
India's 8i Ventures gets 36x return on M2P Fintech
Indian early-stage investor 8i Ventures has made a partial exit of its seed shares in local banking software supplier M2P Fintech, generating a 36x multiple and an IRR of 415% after two years.
TPG, Temasek invest $136m in India's Dr Agarwal’s
TPG Growth and Temasek Holdings have invested a combined INR 10.5bn (USD 136m) in Indian eyecare chain Dr. Agarwal’s Eye Hospital, setting up an exit for ADV Partners.
Actis sells India renewables platform to Shell for $1.55b
Actis has sold Indian renewables platform Sprng Energy, including its flagship solar business Solenergi Power, to Shell Overseas investment for USD 1.55bn.
China delivery player Gogox files for Hong Kong IPO
Gogox, a last-mile logistics company formed through the merger of Hong Kong's GoGoVan and an affiliate of mainland China-based 58.com, has filed to list in Hong Kong
EQT buys China pest control business
EQT Private Equity Asia has acquired majority stake in Guardian Hygiene Service, China’s largest domestic pest control company, for an undisclosed sum. It facilitates a full exit for Jade Invest.
J-Star exits Japan nursing care provider
J-Star has exited dementia-focused nursing care provider Platia to Bain Capital-owned counterpart Nichii Gakkan for an undisclosed sum.
4Q analysis: Record quarter, record year
China rebounds as Asia private equity investment ends 2021 with a bang; bright spots in improving fundraising environment; sponsor-to-sponsor exits thrive while PE-backed IPOs stumble
2021 in review: Boom time
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
CLSA completes exit from Japan cram school
CLSA Capital Partners (CLSA CP) has sold its remaining shares in Japanese cram school operator BC Ings to Eishinkan, a major player in the segment.
AVCJ Awards 2021 - voting has closed
Voting for the 2021 AVCJ Private Equity & Venture Capital Awards has now closed. Many thanks for your participation. The winners will be announced on November 15.
Eneos to buy PE-backed Japan Renewable Energy for $1.8b
Eneos Holdings, an oil company and active technology investor, has agreed to acquire Japan Renewable Energy (JRE) from Goldman Sachs Asset Management and GIC.
